691 results
P
vitrified-warmed day 5 blastocyst transfer (BT), vitrified-warmed day 6 blastocyst transfer (BT)
I/C
vitrified-warmed day 5 BT, vitrified-warmed day 6 BT, vitrified-warmed day 5 BT, vitrified-warmed day 6 BT
O
birth weight, gestational age, number of males, premature delivery, birth defects, neonatal deaths
P
I/C
l, o, w, -, l, e, v, e, l, , a, r, s, e, n, i, c, , (, A, s, ), , c, o, n, c, e, n, t, r, a, t, i, o, n, , i, n, , d, r, i, n, k, i, n, g, , w, a, t, e, r, d, r, i, n, k, i, n, g, , w, a, t, e, r, , A, s, , c, o, n, c, e, n, t, r, a, t, i, o, n, s, , l, o, w, e, r, , t, h, a, n, , t, h, e, , W, H, O, , p, r, o, v, i, s, i, o, n, a, l, , g, u, i, d, e, l, i, n, e, , v, a, l, u, e, , (, 1, 0, , µ, g, /, L, )
O
p, o, o, l, e, d, , a, s, s, o, c, i, a, t, i, o, n, , b, e, t, w, e, e, n, , t, h, e, , r, e, l, a, t, i, v, e, , r, i, s, k, , o, f, , e, a, c, h, , c, a, r, d, i, o, v, a, s, c, u, l, a, r, , d, i, s, e, a, s, e, , (, C, V, D, ), , e, n, d, p, o, i, n, t, , a, n, d, , l, o, w, -, l, e, v, e, l, , A, s, , c, o, n, c, e, n, t, r, a, t, i, o, n, , i, n, , d, r, i, n, k, i, n, g, , w, a, t, e, r
P
health professionals (HPs)
I/C
formal R/S-training, physicians, nurses
O
belief in influence of R/S on patients' health, prevalence of formal R/S-training
P
Casper/Roadsaver, CGuard, Gore stent
I/C
second-generation ('mesh') carotid stents (SGS), carotid endarterectomy (CEA)
O
30-day death (D), stroke (S), myocardial infarction (M), 12-month ipsilateral stroke and restenosis
P
human subjects
I/C
assessment of postural control and gait as a function of time of day, morning, afternoon, evening
O
optimal postural control and gait
P
nurse-led peri-discharge interventions
I/C
usual care, randomized controlled trials
O
all-cause 30-day hospital readmissions
P
patients with acute respiratory distress syndrome (ARDS)
I/C
Neuromuscular blocking agents (NMBAs), placebo (or traditional treatment)
O
90-day mortality, 21-28 days mortality, NMBA-related complications (barotrauma, pneumothorax and intensive care unit (ICU)-acquired muscle weakness), days free of ventilation, days not in the ICU by day 28, Medical Research Council score, Acute Physiology and Chronic Health Evaluation II score, arterial oxygen tension (PaO2)
P
patients undergoing transfemoral TAVI
I/C
Self-expandable (SEV) valve, Balloon-expandable (BEV) valve, SEV vs. BEV
O
30-day incidence of stroke
P
metastatic or recurrent gastric cancer patients
I/C
capecitabine-based chemotherapy, S-1-based chemotherapy
O
objective response rate, 6-, 12-, and 18-month progression-free survival, 1-, 2-, and 3-year overall survival, adverse events (hand-foot syndrome, neutropenia)
P
patients who had undergone laryngectomy
I/C
early oral feeding (before seven days), late oral feeding (after seven days)
O
risk of PCF formation